Mercks New Keytruda Shot Blocked in Europe After Court Loss
2026-10-07 19:18:07Mercks New Keytruda Shot Blocked in Europe After Court Loss Bloomberg.com...
Read MoreHalozyme wins court order to block Merck\'s injected Keytruda in select European markets
2026-10-07 19:03:34Halozyme wins court order to block Merck\'s injected Keytruda in select European markets Reuters...
Read MoreMerck\'s experimental skin disease drug succeeds in mid-stage study
2026-09-30 20:53:26Merck\'s experimental skin disease drug succeeds in mid-stage study Reuters...
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Oct-2026 | Source : BSEPlease find attached signed Certifiacte for confirming compliance under Regulation 74(5) of the SEBI (DP) Regulations for the quarter ended September 30 2026.
Board Meeting Intimation for Intimation Of Board Meeting
30-Sep-2026 | Source : BSEProcter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2026.
Closure of Trading Window
25-Sep-2026 | Source : BSEWe would like to inform you that the Trading Window of the Company shall remain closed for the Directors and Designated Employees from October 1 2026 until 48 hours from the publication of the unaudited financial results for the quarter and half year ended September 30 2026.
Corporate Actions
02 Nov 2026
Procter & Gamble Health Ltd has declared 450% dividend, ex-date: 27 Aug 26
No Splits history available
No Bonus history available
No Rights history available